These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23479965)

  • 21. Associations between neurohormonal and inflammatory activation and heart failure in children.
    Ratnasamy C; Kinnamon DD; Lipshultz SE; Rusconi P
    Am Heart J; 2008 Mar; 155(3):527-33. PubMed ID: 18294492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality.
    Øie E; Ueland T; Dahl CP; Bohov P; Berge C; Yndestad A; Gullestad L; Aukrust P; Berge RK
    J Intern Med; 2011 Sep; 270(3):263-72. PubMed ID: 21466599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy.
    Franz M; Berndt A; Altendorf-Hofmann A; Fiedler N; Richter P; Schumm J; Fritzenwanger M; Figulla HR; Brehm BR
    Eur J Heart Fail; 2009 Nov; 11(11):1057-62. PubMed ID: 19815660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.
    Stanciu AE; Vatasescu RG; Stanciu MM; Iorgulescu C; Vasile AI; Dorobantu M
    Clin Biochem; 2013 Feb; 46(3):230-4. PubMed ID: 23159290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure.
    Zhao YT; Shao L; Teng LL; Hu B; Luo Y; Yu X; Zhang DF; Zhang H
    J Int Med Res; 2009; 37(6):1831-41. PubMed ID: 20146881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide.
    Ho YL; Lin YH; Lee CM; Hsu RB; Ting HT; Chou NK; Chao CL; Wang SS; Hsu HC; Chen MF
    Clin Biochem; 2009 Sep; 42(13-14):1407-12. PubMed ID: 19560452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of biological markers in myocardial infarction patients.
    Berezin AE; Samura TA
    Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):142-50. PubMed ID: 24532611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
    Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
    Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [RELATIONSHIP BETWEEN SMOKING AND INDICATORS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE].
    Bazdyrev ED; Polikutina OM; Kalichenko NA; Slepynina YS; Uchasova EG; Pavlova VY; Barbarash OL
    Klin Med (Mosk); 2017; 95(3):264-71. PubMed ID: 30303364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 1999 Apr; 42(1):162-72. PubMed ID: 10435007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
    Kaye DM; Khammy O; Mariani J; Maeder MT
    Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can we ask the lab how much extra fluid patients carry?
    Stompór TP
    Nephron Clin Pract; 2004; 97(4):c123-4. PubMed ID: 15331940
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive symptoms and inflammation in patients hospitalized for heart failure.
    Johansson P; Lesman-Leegte I; Svensson E; Voors A; van Veldhuisen DJ; Jaarsma T
    Am Heart J; 2011 Jun; 161(6):1053-9. PubMed ID: 21641350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of changes in concentration of brain natriuretic peptide, TNF-alpha factor and Interleukin-6 in chronic cardiac failure].
    Volkova SIu
    Klin Med (Mosk); 2008; 86(7):18-22. PubMed ID: 18756741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6.
    Dolenc J; Šebeštjen M; Vrtovec B; Koželj M; Haddad F
    Biomarkers; 2014 Aug; 19(5):385-90. PubMed ID: 24831174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study.
    van Boven N; Battes LC; Akkerhuis KM; Rizopoulos D; Caliskan K; Anroedh SS; Yassi W; Manintveld OC; Cornel JH; Constantinescu AA; Boersma E; Umans VA; Kardys I
    Am Heart J; 2018 Feb; 196():36-48. PubMed ID: 29421013
    [No Abstract]   [Full Text] [Related]  

  • 39. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
    Song YH; Cai H; Gu N; Qian CF; Cao SP; Zhao ZM
    J Pharm Pharmacol; 2011 Apr; 63(4):541-9. PubMed ID: 21401606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
    Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.